Role of Androgen Ablation with Low-Dose-Rate Brachytherapy in the Treatment of Prostate Cancer

Author： Jani Ashesh B.   Shoushtari Asal   Feinstein Jeffrey M.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.12, 2006-01, pp. : 723-731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controversies of Androgen Ablation Therapy for Metastatic Prostate Cancer

By  

Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. : 799-805

Bentham Science Publishers

Access to resources Recommend Favorite

Akt in Prostate Cancer: Possible Role in Androgen-Independence

By  

Current Drug Metabolism, Vol. 4, Iss. 6, 2003-12 ,pp. : 487-496

Bentham Science Publishers

Access to resources Recommend Favorite

Prostate Brachytherapy: An Option in the Treatment of Early Stage Prostate Cancer

By Glegg M.   Dodds D.   Baxter G.M.  

UroOncology, Vol. 4, Iss. 2, 2004-06 ,pp. : 53-69

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Androgen Receptor Antagonists in the Treatment of Prostate Cancer

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 1, Iss. 1, 2014-06 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

New Features in the Treatment of Androgen-Independent Prostate Cancer

By  

Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite